Earnings History Data for Kymera Therapeutics, Inc. (KYMR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Kymera Therapeutics, Inc.

Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
31-10-2024	PM		KYMR	Kymera Therapeutics, Inc.	2,990	-0.82	-0.83	-0.90	Kymera Therapeutics GAAP EPS of -$0.82 beats by $0.02, revenue of $3.74M misses by $6.6M [10/31/2024 7:40 AM]	46.19	-1.48 (-3.10%)	45.01	-2.66 (-5.58%)	9.60 - 53.27	633,751	330,000	1,449
Kymera Therapeutics GAAP EPS of -$0.82 beats by $0.02, revenue of $3.74M misses by $6.6M [10/31/2024 7:40 AM] Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update [2024-10-31 07:30AM] Kymera Therapeutics Inc (KYMR) Q3 2024: Everything You Need To Know Ahead Of Earnings [Oct-30-24 09:10AM]
07-08-2024	PM		KYMR	Kymera Therapeutics, Inc.	2,580	-0.58	-0.69	-0.67	Kymera Therapeutics GAAP EPS of -$0.58 beats by $0.12, revenue of $25.7M beats by $13.15M [8/7/2024 7:47 AM]	40.56	-0.86 (-2.06%)	0.0	0.0 (0.00%)	9.60 - 48.70	331,711	520,000	0
Kymera Therapeutics GAAP EPS of -$0.58 beats by $0.12, revenue of $25.7M beats by $13.15M [8/7/2024 7:47 AM]
02-05-2024	PM		KYMR	Kymera Therapeutics, Inc.	2,120	-0.69	-0.73	-0.70	Kymera Therapeutics GAAP EPS of -$0.69 beats by $0.04, revenue of $10.3M misses by $2.75M [5/2/2024 7:23 AM]	36.25	0.01 (0.03%)	0.0	0.0 (0.00%)	9.60 - 45.31	360,977	530,000	0
Kymera Therapeutics Q1 2024 Earnings Preview [5/1/2024 11:39 AM] Kymera Therapeutics GAAP EPS of -$0.69 beats by $0.04, revenue of $10.3M misses by $2.75M [5/2/2024 7:23 AM]
22-02-2024	PM		KYMR	Kymera Therapeutics, Inc.	2,140	-0.25	-0.44	-0.60	Kymera Therapeutics GAAP EPS of -$0.25 beats by $0.06, revenue of $47.9M beats by $5.91M [2/22/2024 7:20 AM]	40.52	1.85 (4.78%)	0.0	0.0 (0.00%)	9.60 - 42.68	692,761	650,000	0
Kymera Therapeutics Q4 2023 Earnings Preview [2/21/2024 11:27 AM] Kymera Therapeutics GAAP EPS of -$0.25 beats by $0.06, revenue of $47.9M beats by $5.91M [2/22/2024 7:20 AM]
02-11-2023	PM		KYMR	Kymera Therapeutics, Inc.	646.66	-0.90	-0.73	-0.79	Kymera Therapeutics GAAP EPS of -$0.90 misses by $0.19, revenue of $4.73M misses by $11.24M [11/2/2023 7:25 AM]	12.08	0.53 (4.59%)	12.08	0.0 (0.00%)	9.60 - 39.85	1,518,715	540,000	1,998
Kymera Therapeutics GAAP EPS of -$0.90 misses by $0.19, revenue of $4.73M misses by $11.24M [11/2/2023 7:25 AM]
03-08-2023	PM		KYMR	Kymera Therapeutics, Inc.	1,200	-0.67	-0.70	-0.78	Kymera Therapeutics GAAP EPS of -$0.67 beats by $0.06, revenue of $16.51M beats by $2.77M [8/3/2023 7:30 AM]	23.88	2.38 (11.07%)	23.88	0.0 (0.00%)	18.84 - 39.85	685,996	340,000	8,752
Kymera Therapeutics GAAP EPS of -$0.67 beats by $0.06, revenue of $16.51M beats by $2.77M [8/3/2023 7:30 AM]
04-05-2023	PM	7:05 AM ET (May 4)	KYMR	Kymera Therapeutics, Inc.	1,670	-0.70	-0.69	-0.71	Kymera Therapeutics GAAP EPS of -$0.70 beats by $0.01, revenue of $9.5M misses by $4.65M [5/4/2023 7:30 AM]	26.21	-4.68 (-15.16%)	30.01	-0.89 (-2.88%)	13.15 - 39.85	1,166,734	380,000	150
Kymera Therapeutics GAAP EPS of -$0.70 beats by $0.01, revenue of $9.5M misses by $4.65M [5/4/2023 7:30 AM] Kymera off 14% on quarterly results, lack of clarity on trial [5/4/2023 3:41 PM]
23-02-2023	PM	7:05 AM ET (Feb 23)	KYMR	Kymera Therapeutics, Inc.	1,850	-0.60	-0.57	-0.66	Kymera Therapeutics GAAP EPS of -$0.60 beats by $0.03, revenue of $16.1M misses by $4.56M [2/23/2023 7:20 AM]	33.17	1.64 (5.20%)	0.0	0.0 (0.00%)	13.15 - 44.74	395,755	460,000	0
Kymera Therapeutics GAAP EPS of -$0.60 beats by $0.03, revenue of $16.1M misses by $4.56M [2/23/2023 7:20 AM]
03-11-2022	PM	7:00 AM ET (Nov 3)	KYMR	Kymera Therapeutics, Inc.	1,640	-0.79	-0.70	-0.56	Kymera Therapeutics GAAP EPS of -$0.79 misses by $0.05, revenue of $9.54M misses by $6.4M [11/3/2022 7:21 AM]	31.03	2.28 (7.93%)	28.24	-0.51 (-1.77%)	13.15 - 69.12	446,185	670,000	696
Kymera Therapeutics GAAP EPS of -$0.79 misses by $0.05, revenue of $9.54M misses by $6.4M [11/3/2022 7:21 AM] Kymera Therapeutics Announces Third Quarter 2022 Financial Results and Provides a Business Update [Nov-03-22 07:05AM] Kymera Therapeutics Appoints Biopharmaceutical Leader Victor Sandor, M.D.C.M., to Board of Directors [Nov-03-22 07:00AM]
09-08-2022	PM	7:00 AM ET (Aug 9)	KYMR	Kymera Therapeutics, Inc.	1,120	-0.78	-0.68	-0.55	Kymera Therapeutics GAAP EPS of -$0.78 misses by $0.08, revenue of $11.51M misses by $3.46M [8/9/2022 7:11 AM]	30.32	-1.11 (-3.53%)	28.91	-2.52 (-8.02%)	13.15 - 69.12	494,631	680,000	11,486
Kymera Therapeutics GAAP EPS of -$0.78 misses by $0.08, revenue of $11.51M misses by $3.46M [8/9/2022 7:11 AM] Kymera Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Business Update [Aug-09-22 07:00AM]
03-05-2022	PM	7:00 AM ET (May 3)	KYMR	Kymera Therapeutics	1,680	-0.71	-0.67	0.00	Kymera Therapeutics GAAP EPS of -$0.71 misses by $0.05, revenue of $9.62M misses by $9.04M [5/3/2022 7:04 AM]	24.88	-7.85 (-23.98%)	32.73	0.0 (0.00%)	23.16 - 69.12	2,112,958	440,000	18,920
Kymera Therapeutics GAAP EPS of -$0.71 misses by $0.05, revenue of $9.62M misses by $9.04M [5/3/2022 7:04 AM] Kymera hits 52-week low after earnings miss and pipeline update [5/3/2022 10:11 AM] Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update [May-03-22 07:00AM] Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Lags Revenue Estimates [May-03-22 08:15AM] Why Kymera Therapeutics Shares Are Falling Today [May-03-22 02:18PM]
24-02-2022	PM	7:00 AM ET (Feb 24)	KYMR	Kymera Therapeutics	1,989	-0.66	-0.36	0.00	Kymera Therapeutics GAAP EPS of -$0.66 misses by $0.09, revenue of $15.27M misses by $6.04M [2/24/2022 7:47 AM]	42.59	2.43 (6.05%)	0.0	0.0 (0.00%)	29.93 - 69.12	37,473	373,820	0
Kymera Therapeutics GAAP EPS of -$0.66 misses by $0.09, revenue of $15.27M misses by $6.04M [2/24/2022 7:47 AM] Kymera Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides a Business Update [Feb-24-22 07:00AM] Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Lags Revenue Estimates [Feb-24-22 10:15AM]
10-11-2021	PM		KYMR	Kymera Therapeutics	3,346	-0.56	-0.34	0.00	Kymera Therapeutics EPS misses by $0.11, beats on revenue [11/10/2021 8:45 AM]	63.79	-1.77 (-2.70%)	0.0	0.0 (0.00%)	29.93 - 91.92	202,467	290,000	0
Kymera Therapeutics EPS misses by $0.11, beats on revenue [11/10/2021 8:45 AM] Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Tops Revenue Estimates [Nov-10-21 08:25AM] Kymera Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Business Update [Nov-10-21 07:00AM]
06-08-2021	PM		KYMR	Kymera Therapeutics, Inc.	3,000	-0.55	-0.21	0.00	Kymera Therapeutics EPS misses by $0.26, misses on revenue [8/6/2021 7:29 AM]	59.41	-2.86 (-4.59%)	63.00	0.73 (1.17%)	25.43 - 91.92	288,197	330,000	214
Kymera Therapeutics EPS misses by $0.26, misses on revenue [8/6/2021 7:29 AM] Kymera Therapeutics Announces Second Quarter 2021 Financial Results and Provides a Business Update [Aug-06-21 07:00AM]
06-05-2021	PM		KYMR	Kymera Therapeutics, Inc.	1,884	-0.29	-0.17	0.00	Kymera Therapeutics EPS misses by $0.14, misses on revenue [5/6/2021 7:36 AM]	40.98	-0.26 (-0.63%)	40.98	0.0 (0.00%)	25.43 - 91.92	334,942	320,000	133
Kymera Therapeutics EPS misses by $0.14, misses on revenue [5/6/2021 7:36 AM] Kymera Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update [May-06-21 07:00AM] Kymera Therapeutics Appoints Juliet Williams, PhD, as Senior Vice President, Head of Biology [May-05-21 07:00AM]
11-03-2021	PM		KYMR	Kymera Therapeutics, Inc.	2,140	-0.29	0.02	0.00	Kymera Therapeutics EPS misses by $0.12, misses on revenue [3/11/2021 7:42 AM]	59.14	1.78 (3.11%)	59.29	1.93 (3.36%)	25.43 - 91.92	470,018	329,733	353
Kymera Therapeutics EPS misses by $0.12, misses on revenue [3/11/2021 7:42 AM] Kymera Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides a Business Update [Mar-11-21 07:00AM]